A promising COVID-19 treatment has been fast-tracked
The FDA has approved a clinical trial for a convalescent serum therapy to treat COVID-19 using blood plasma from recovered patients.
The FDA has approved a clinical trial for a convalescent serum therapy to treat COVID-19 using blood plasma from recovered patients.